NUR-635-Midterm Questions with Correct Answers

NUR-635-Midterm

Alzheimer's Disease (AD) - answer Development of neurofibrillary tangles in the CNS

Beta-amyloid plaque - answer Pathological change in Alzheimer's Disease (AD)

Donepezil (Aricept) - answer Pharmacologic agent for Alzheimer's Disease (AD) with
longer duration of activity

Galantamine (Razadyne) - answer Pharmacologic agent for Alzheimer's Disease (AD)

Memantine (Namenda) - answer Pharmacologic agent for Alzheimer's Disease (AD)
that is a NMDA antagonist

Rivastigmine (Exelon) - answer Pharmacologic agent for Alzheimer's Disease (AD)
available as a patch and a liquid preparation

Antiepileptic Agents - answerDrugs that reduce seizure activity

Epilepsy - answerThird most common neurologic disorder characterized by seizure
activity

Generalized seizure types - answerTypes of seizures with loss of consciousness and no
memory of the event

Status epilepticus - answerTwo or more seizures without full consciousness between
episodes

Absence seizures - answerSeizures with impaired consciousness, typically seen in
children

Focal seizure types - answerTypes of seizures that include simple partial and complex
partial seizures

Antiepileptic drugs - answerDrugs that reduce seizure activity by various mechanisms

Carbamazepine - answerAntiepileptic drug with black box warning of severe
dermatologic reactions

Phenytoin (Dilantin) - answerAntiepileptic drug that is highly plasma protein bound

Fosphenytoin - answerProdrug converted to phenytoin, administered intramuscularly